Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellspect Healthcare is a leading global provider of innovative medical devices specializing in continence care. Headquartered in Mölndal, Sweden, the company is best known for its LoFric brand of intermittent urinary catheters and the Navina transanal irrigation system. Wellspect focuses on developing solutions that improve the quality of life for individuals suffering from bladder and bowel dysfunction, often caused by neurological conditions such as spinal cord injuries or multiple sclerosis. Originally the healthcare division of Astra Tech, the company was rebranded as Wellspect Healthcare following its acquisition by Dentsply Sirona. Today, it maintains a significant international presence, marketing its products in over 30 countries with a strong emphasis on clinical evidence and environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellspect Healthcare.